Deal leverages Strata Trial, a program to sequence 100,000 advanced cancer patients to expand patient access to clinical trials.
UCLA researchers modify technique previously used for gene inactivation so it can be used to introduce particular DNA sequences, or patches
If a genetic variant is the origin and a disease the destination, the biochemical path between them may appear on a map of a...
Poor infiltration of the tumor by immune cells, low activity from available T cells, a lack of immune-stimulating neoantigens, and multiple immune-suppressing pathways all combine to hinder response to immunotherapy.
By restricting the dietary amino acids serine and glycine, which in turn targeted the serine synthesis enzyme phosphoglycerate dehydrogenase, the team induced tumor cells to produce a toxic lipid that slows cancer progression in mice.
Sift through metadata. Track contact activity. Identify suspicious patterns. This to-do list sounds as though it were devised by the National Security Agency. But...
The 10-year partnership will see the companies develop a secure, cloud-based informatics environment for the ambitious research initiative
Washington will keep its eye on clinical laboratories this year—specifically, how much they are billing the federal government for services through Medicare. The U.S. Department...
Blood-based test, designed to detect genomic alterations and epigenomic signatures, is set for clinical launch in the second half of 2019
Qiagen launches improved version of its QCI-Interpret software incorporating AMP/ASCO/CAP guidelines for interpreting cancer variants